1. The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
- Author
-
Hongyan Ban, Jinsong Ni, Yafang Liu, and Jixuan Liu
- Subjects
Adult ,Male ,Cell biology ,Science ,Aldo-Keto Reductases ,Matrix metalloproteinase ,Article ,chemistry.chemical_compound ,Breast cancer ,Cell Movement ,medicine ,Carcinoma ,Biomarkers, Tumor ,Humans ,Hormone metabolism ,Lung cancer ,Laryngeal Neoplasms ,Aged ,Cell Proliferation ,Cancer ,Multidisciplinary ,Cell growth ,business.industry ,Hep G2 Cells ,Middle Aged ,medicine.disease ,Tumor Burden ,Up-Regulation ,chemistry ,A549 Cells ,Lymphatic Metastasis ,Cancer research ,Carcinoma, Squamous Cell ,Matrix Metalloproteinase 2 ,Medicine ,Female ,Tumor Suppressor Protein p53 ,business ,Nicotinamide adenine dinucleotide phosphate - Abstract
Aldosterone reductase family 1 member B10 (AKR1B10) is a nicotinamide adenine dinucleotide phosphate (NADPH) (reduced coenzyme II)-dependent oxidoreductase, and its biological functions include carbonyl detoxification, hormone metabolism, osmotic adjustment, and lipid synthesis. Studies suggested that AKR1B10 is a new biomarker for cancer based on its overexpression in epithelial tumors, such as breast cancer, cervical cancer, and lung cancer. At present, studies on the expression of AKR1B10 in laryngeal cancer have not been reported. However, we found that AKR1B10 is upregulated in laryngeal carcinoma, and its expression was negatively correlated with the degree of differentiation. In addition, AKR1B10 expression was positively correlated with tumor size; lymph node metastasis; long-term drinking; and Ki-67, mutant p53, and matrix metalloproteinase 2 expression. AKR1B10 was overexpressed in Hep-2 laryngeal carcinoma cells. Oleanolic acid inhibited AKR1B10 activity and expression in Hep-2 cells and suppressed Hep-2 cell proliferation, migration, and invasion. Therefore, AKR1B10 may be related to the development of laryngeal carcinoma, suggesting its use as a prognostic indicator for laryngeal cancer.
- Published
- 2021